BLADDER CARCINOMA
Clinical trials for BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Vaccine-Immunotherapy combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a vaccine (p53MVA) plus the drug pembrolizumab in 11 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the combination is safe and can boost the immune system to attack cancer cells. Participant…
Matched conditions: BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 16, 2026 23:51 UTC
-
Special nutrition may cut complications after bladder cancer surgery
Disease control OngoingThis study tests whether a special nutrition drink, given before and after bladder removal surgery, can boost the immune system and reduce problems like infections. About 200 adults with bladder cancer are taking part. The goal is to see if better nutrition leads to fewer complic…
Matched conditions: BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Bladder cancer drug combo trial halted before enrolling a single patient
Disease control TerminatedThis study aimed to test two treatments for muscle-invasive bladder cancer in patients who cannot receive the standard chemotherapy drug cisplatin. The treatments were erdafitinib (a targeted pill) alone or combined with atezolizumab (an immunotherapy). The goal was to see if the…
Matched conditions: BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New PET tracer could reveal hidden cancers
Knowledge-focused OngoingThis early-phase study tests a new imaging agent called 68Ga-FAPI-46, which targets cells around tumors. About 26 adults with various cancers will receive the tracer and then have a PET/CT scan. The goal is to see where the tracer goes in the body and compare it to standard imagi…
Matched conditions: BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC